Synthetic peptide significantly enhances the only currently approved drug to get blood flow moving to the brain after a stroke.


In the not-so-distant future, people blinded by retinitis pigmentosa may be using Israeli technology to see beyond shadows once again.

Synthetic peptide significantly enhances the only currently approved drug to get blood flow moving to the brain after a stroke.
An Israeli pharma company is testing an advanced compound that blocks a tumor’s blood supply. Used with standard chemo, it obliterates the growth.
A new Israeli study shows that with support from the supervisor, a stressed employee is less likely to need days off to recover.
Bold new three-year collaboration gives the global pharma giant access to the Weizmann Institute’s bright ideas in medical treatment and diagnosis.
A simple bedside test to be available soon in Europe may be the most potent weapon against hospital-borne infection to date.
The first Israeli study of its kind finds 90% of active firefighters exhibit symptoms of post-traumatic stress disorder, and suggests how to improve the numbers.
Israeli university researchers unveil their discovery of a gene that increases the lifespan of lab animals, and perhaps of humans too.
The simple new check shows a 90 percent detection rate in clinical tests for multiple types of cancers.
Israeli company’s LiteTouch laser system is becoming a fast favorite of dentists and their patients in the US, Asia and Europe.
Hebrew University scientists genetically alter fast-growing tobacco to produce a natural compound known to fight drug-resistant malaria.
Slider by Aesthetic